会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明公开
    • Lactic acid bacteria combination and compositions thereof
    • Milchsäurebakterienkombinationund deren Zusammensetzungen
    • EP1481681A1
    • 2004-12-01
    • EP03425349.2
    • 2003-05-30
    • De Simone, Claudio
    • De Simone, Claudio
    • A61K35/74A23L1/03
    • A61K35/745A23K10/18A23L29/065A23L33/135A23Y2220/65A23Y2240/75A23Y2300/49A61K35/741A61K35/744A61K35/747
    • The present invention provides prophylaxis and treatment of dismicrobial conditions by means of combinations of highly concentrated lactic acid bacteria, compositions containing them suitable for administration to mammals, their use as medicaments or food supplements, in particular suitable for the prevention and/or treatment of a number of diseases, in particular imbalances of the natural flora of mammals.
      According to the general concept of the present invention, the lactic acid bacteria combination consists of:

      (a) from about 5% to about 95% by weight of total combination of Lactobacillus pentosus and
      (b) from about 5% to about 95% by weight of total combination of at least one strain of Streptococcus thermophilus and/or Lactobacillus paracasei and/or Lactobacillus helveticus; and/or mutants or derivatives of (a) and/or (b).

      Examples of diseases or disturbances to be treated are imbalances of bacteria flora, inflammatory condition or a degenerative disease of the gastrointestinal tract, liver, pancreas, vagina, mouth, anus or any fistolous tract.
    • 乳酸菌组合(I)包含5-95重量%的戊糖酸乳杆菌的总组合和5-95重量%的嗜热链球菌和/或乳酸链球菌和/或L.helveticus的总组合和/或它们的 突变体或衍生物,是新的。 对于包含(I),与赋形剂混合的组合物(II),还包括独立权利要求。 活性:抗炎; 胃肠道根; 抗溃疡; 泻药; 止泻; 低血压; 抗菌; 降血糖; 抑制细胞生长; 免疫抑制。 体内测定乳酸菌组成的抗腹泻活性。 接受氟嘧啶治疗继发性腹膜炎的32例癌症患者接受治疗。 16例患者接受嗜热链球菌5.71X101> 1>,副干酪乳杆菌7.93X101> 0>,苦参杆菌1.59X101> 0>嗜酸乳杆菌3.18X101> 0>,L.helveticus 1.59X101> 0> B. 1.42X101> 1>,B.lactis 2.12X109>,B.bifidum 1.42X101> 1>,每天两包,共4天。 在这段时间结束时,16名治疗的患者中有9例解除了腹泻。 作用机理:调节COX-2活性; 灭活细胞因子(要求保护)。
    • 9. 发明公开
    • Dietetic and/or pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
    • 冻干的细菌膳食或药物组合物含有,制备及其用途。
    • EP0555618A2
    • 1993-08-18
    • EP92830653.9
    • 1992-12-04
    • Cavaliere Vesely, Renata Maria AnnaDe Simone, Claudio
    • Cavaliere Vesely, Renata Maria AnnaDe Simone, Claudio
    • A23L1/03A61K35/74
    • A61K35/744A23L29/065A23Y2220/67A23Y2240/75A23Y2300/55A61K35/745A61K35/747A61K45/06A61K2300/00
    • Pharmaceutical compositions containing highly-concentrated lyophilized lactic bacteria in combination with pharmacologically acceptable excipients and optionally suitable physiologically compatible drugs, are adapted for restoring the intestinal mucous membrane mass and modulating the epithelial cell kinetics and the enzyme potential of the intestine when they have been altered as a result of stress conditions, and in, addition in case of gastroenteritis, colitis, constipation, diarrhoea, for recolonizing the intestine after food disorders, surgical interventions, chemotherapy or contagious deseases, hepatopathies resulting from toxic, metabolic or infectious causes, as adjuvants for controlling hyperammonemia and endotoxinemia while liver insufficiency is in progress, in case of lack of humoral immunity and of mucosal and systemic cell-mediated immunity associated with secondary immunological deficiency diseases, for hyperlipoproteinemia and hypercholesteremia, and as adjuvants in diabetes therapy.
    • 药物组合物含有高浓度的冻干乳酸菌组合与药理学上可接受的赋形剂和任选的合适的生理上相容的药物,被angepasst用于恢复肠粘膜质量和调制上皮细胞动力学和肠的酶潜在当它们havebeen改变作为 的应力条件的结果,并在,除了在胃肠炎,结肠炎,便秘,腹泻,用于食品障碍,外科手术,化疗或传染性deseases后recolonising肠,hepatopathies从毒性,代谢或感染原因引起的情况下,作为佐剂 控制高氨血症和内毒素血症,而肝功能不全正在进行中,在缺乏体液免疫和粘膜,并用二次免疫缺陷性疾病,高脂蛋白血症为高胆固醇血症和相关的全身细胞介导的免疫的情况下,并且如在直径佐剂 betes治疗。